Document is current
Any future updates will be listed below
-
Authors
Xie, Yizhao
Chen, Yifan
Liu, Cheng
Zhao, Yannan
Gong, Chengcheng
Lin, Shuyi
Song, Shaoli
Wang, Biyun
Yang, Zhongyi https://orcid.org/0000-0001-6195-9942
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82102722)
National Natural Science Foundation of China (82373340)
Beijing Science and Technology Innovation Medical Development Foundation (KC2022-ZZ-0091-4)
Beijing Xisike Clinical Oncology Research Foundation (Y-Young2022—0286)
Beijing Xisike Clinical Oncology Research Foundation (Y-2022HER2AZQN-0378)
- License Information
-
More Information
Article History
Received: 7 May 2025
Accepted: 6 July 2025
First Online: 19 July 2025
Declarations
:
: This study has been approved by the Ethics Committee and Institutional Review Board (IRB) of Fudan University Shanghai Cancer Center (FUSCC) (IRB approval number: 1812195–6). The need for informed consent was waived, owing to the retrospective nature of the study in accordance with the national legislation and institutional requirements.
: The need of written consent to participate was waived owing to the retrospective nature of this study.
: The authors declare that there is no conflict of interest.
: The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
